Details for New Drug Application (NDA): 020490
✉ Email this page to a colleague
NDA 020490 describes ALPHAGAN, which is a drug marketed by Allergan and Abbvie and is included in four NDAs. Additional details are available on the ALPHAGAN profile page.
The generic ingredient in ALPHAGAN is brimonidine tartrate. There is one drug master file entry for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate profile page.
The generic ingredient in ALPHAGAN is brimonidine tartrate. There is one drug master file entry for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate profile page.
Summary for 020490
| Tradename: | ALPHAGAN |
| Applicant: | Allergan |
| Ingredient: | brimonidine tartrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020490
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.5% | ||||
| Approval Date: | Mar 13, 1997 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
